Literature DB >> 11470914

Rac1 mediates STAT3 activation by autocrine IL-6.

T R Faruqi1, D Gomez, X R Bustelo, D Bar-Sagi, N C Reich.   

Abstract

The activity of the small GTPase, Rac1, plays a role in various cellular processes including cytoskeletal rearrangement, gene transcription, and malignant transformation. In this report constitutively active Rac1 (Rac V12) is shown to stimulate the activation of STAT3, a member of the family of signal transducers and activators of transcription (STATs). The activity of Rac1 leads to STAT3 translocation to the nucleus coincident with STAT3-dependent gene expression. The expression of Vav (Delta1-187), a constitutively active guanine nucleotide exchange factor for the Rho GTPases, or activated forms of Ras or Rho family members, leads to STAT3-specific activation. The activation of STAT3 requires tyrosine phosphorylation at residue 705, but is not dependent on phosphorylation of Ser-727. Our studies indicate that Rac1 induces STAT3 activation through an indirect mechanism that involves the autocrine production and action of IL-6, a known mediator of STAT3 response. Rac V12 expression results in the induction of the IL-6 and IL-6 receptor genes and neutralizing antibodies directed against the IL-6 receptor block Rac1-induced STAT3 activation. Furthermore, inhibition of the nuclear factor-kappaB activation or disruption of IL-6-mediated signaling through the expression of IkappaBalpha S32AS36A and suppressor of cytokine signaling 3, respectively, blocks Rac1-induced STAT3 activation. These findings elucidate a mechanism dependent on the induction of an autocrine IL-6 activation loop through which Rac1 mediates STAT3 activation establishing a link between oncogenic GTPase activity and Janus kinase/STAT signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470914      PMCID: PMC55365          DOI: 10.1073/pnas.161281298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Regulation of STAT3 by direct binding to the Rac1 GTPase.

Authors:  A R Simon; H G Vikis; S Stewart; B L Fanburg; B H Cochran; K L Guan
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins.

Authors:  S Uddin; F Lekmine; N Sharma; B Majchrzak; I Mayer; P R Young; G M Bokoch; E N Fish; L C Platanias
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

4.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

5.  Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression.

Authors:  P Kovarik; M Mangold; K Ramsauer; H Heidari; R Steinborn; A Zotter; D E Levy; M Müller; T Decker
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

6.  Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

Authors:  J Turkson; T Bowman; J Adnane; Y Zhang; J Y Djeu; M Sekharam; D A Frank; L B Holzman; J Wu; S Sebti; R Jove
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

7.  Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.

Authors:  J J Schuringa; L J Jonk; W H Dokter; E Vellenga; W Kruijer
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

8.  Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.

Authors:  D Joyce; B Bouzahzah; M Fu; C Albanese; M D'Amico; J Steer; J U Klein; R J Lee; J E Segall; J K Westwick; C J Der; R G Pestell
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

9.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Authors:  J R Grandis; S D Drenning; Q Zeng; S C Watkins; M F Melhem; S Endo; D E Johnson; L Huang; Y He; J D Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

10.  Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080.

Authors:  R Brown; C J Marshall; S G Pennie; A Hall
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  55 in total

1.  Modulation of human enteric epithelial barrier and ion transport function by Peyer's patch lymphocytes.

Authors:  Jie Chen; Lai-Ling Tsang; Lok-Sze Ho; Dewi-K Rowlands; Jie-Ying Gao; Chuen-Pei Ng; Yiu-Wa Chung; Hsiao-Chang Chan
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 3.  Multifaceted role of Rho proteins in angiogenesis.

Authors:  Sofia D Merajver; Saad Z Usmani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

4.  Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway.

Authors:  Robert S Tacke; Annie Tosello-Trampont; Virginia Nguyen; David W Mullins; Young S Hahn
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

5.  Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation.

Authors:  Peng-Chieh Chen; Hiroko Wakimoto; David Conner; Toshiyuki Araki; Tao Yuan; Amy Roberts; Christine E Seidman; Roderick Bronson; Benjamin G Neel; Jonathan G Seidman; Raju Kucherlapati
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

6.  Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression.

Authors:  Zhipeng Wang; Haifeng Jin; Ruodan Xu; Qibing Mei; Daiming Fan
Journal:  Exp Mol Med       Date:  2009-10-31       Impact factor: 8.718

7.  Antagonism of the Stat3-Stat3 protein dimer with salicylic acid based small molecules.

Authors:  Steven Fletcher; Brent D G Page; Xialoei Zhang; Peibin Yue; Zhi Hua Li; Sumaiya Sharmeen; Jagdeep Singh; Wei Zhao; Aaron D Schimmer; Suzanne Trudel; James Turkson; Patrick T Gunning
Journal:  ChemMedChem       Date:  2011-05-25       Impact factor: 3.466

8.  Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation.

Authors:  Hsiao-Ling Cheng; Shu-Jem Su; Li-Wen Huang; Bau-Shan Hsieh; Yu-Chen Hu; Thu-Ching Hung; Kee-Lung Chang
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

9.  A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.

Authors:  Li Lin; Brian Hutzen; Pui-Kai Li; Sarah Ball; Mingxin Zuo; Stephanie DeAngelis; Elizabeth Foust; Matthew Sobo; Lauren Friedman; Deepak Bhasin; Ling Cen; Chenglong Li; Jiayuh Lin
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

10.  ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.

Authors:  Salvador Aznar Benitah; Pilar F Valerón; Juan Carlos Lacal
Journal:  Mol Biol Cell       Date:  2003-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.